Although the signal transduction mechanisms triggered by RFPL3 and its regulation on hTERT promoter activity are not entirely understood and further study is required, our results reveal a new mechanism of hTERT regulation in lung cancer cells and suggest the RFPL3/CBP/hTERT signaling pathway may be a new targets for lung cancer treatment. This evidence concerns the gene RFPL3 and lung carcinoma.